PIROXICAM Drug Patent Profile
When do Piroxicam patents expire, and when can generic versions of Piroxicam launch?
Piroxicam is a drug marketed by Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Pharmobedient, SCS, Solis Pharms, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences. and is included in twenty-two NDAs.
The generic ingredient in PIROXICAM is piroxicam. Ten suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Piroxicam
A generic version of PIROXICAM was approved as piroxicam by TEVA on December 11th, 1992.
